Nebulizers - Medical Devices Pipeline Assessment, 2020

Nebulizers - Medical Devices Pipeline Assessment, 2020

Summary

GlobalData's Medical Devices sector report, “Nebulizers - Medical Devices Pipeline Assessment, 2020 provides an overview of Nebulizers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Incontinence Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Nebulizers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Nebulizers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Nebulizers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • Introduction
    • Nebulizers Overview
  • Products under Development
    • Nebulizers - Pipeline Products by Stage of Development
      • Table Figure 1: Nebulizers - Pipeline Products by Stage of Development
      • Table Nebulizers - Pipeline Products by Stage of Development
    • Nebulizers - Pipeline Products by Segment
      • Table Figure 1: Nebulizers - Pipeline Products by Segment
      • Table Nebulizers - Pipeline Products by Segment
    • Nebulizers - Pipeline Products by Territory
      • Table Figure 2: Nebulizers - Pipeline Products by Territory
      • Table Nebulizers - Pipeline Products by Territory
    • Nebulizers - Pipeline Products by Regulatory Path
      • Table Figure 3: Nebulizers - Pipeline Products by Regulatory Path
      • Table Nebulizers - Pipeline Products by Regulatory Path
    • Nebulizers - Pipeline Products by Estimated Approval Date
      • Table Figure 4: Nebulizers - Pipeline Products by Estimated Approval Date
      • Table Nebulizers - Pipeline Products by Estimated Approval Date
    • Nebulizers - Ongoing Clinical Trials
      • Table Figure 5: Nebulizers - Ongoing Clinical Trials
      • Table Nebulizers - Ongoing Clinical Trials
  • Nebulizers - Pipeline Products under Development by Companies
    • Nebulizers Companies - Pipeline Products by Stage of Development
      • Table Nebulizers Companies - Pipeline Products by Stage of Development
    • Nebulizers – Companies Pipeline Products by Stage of Development
      • Table Nebulizers – Companies Pipeline Products by Stage of Development
  • Nebulizers Companies and Product Overview
    • Ablynx NV Company Overview
      • Ablynx NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ablynx NV Pipeline Products & Ongoing Clinical Trials Overview
        • Table Customised Infant Inhalation Device - Product Status
        • Table Customised Infant Inhalation Device - Product Description
    • Aeon Research & Technology Company Overview
      • Aeon Research & Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aeon Research & Technology Pipeline Products & Ongoing Clinical Trials Overview
        • Table LYNX Nebulizer - Product Status
        • Table LYNX Nebulizer - Product Description
    • AFT Pharmaceuticals Ltd Company Overview
      • AFT Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table AFT Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table NasoSURF - Product Status
        • Table NasoSURF - Product Description
        • Table AFT Pharmaceuticals Ltd - Ongoing Clinical Trials Overview
        • Table NasoSURF - A Single Center, Randomized, Controlled, Four Way Cross-over Clinical Study Investigating the Deposition of Aerosol Generated by the Nasal Mesh Nebulizer (NMN) Prototype into the Nasal Cavity Using Radio-labelled Saline at Different Pulse Frequency in Healthy Volunteers
    • Aura Medical Company Overview
      • Aura Medical Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aura Medical Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nebican - Product Status
        • Table Nebican - Product Description
    • Baby's Breath Ltd. Company Overview
      • Baby's Breath Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Baby's Breath Ltd. Pipeline Products & Ongoing Clinical Trials Overview
        • Table WiseAir - Product Status
        • Table WiseAir - Product Description
    • Creare LLC Company Overview
      • Creare LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Creare LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table DDC-Based Nebulizer - Product Status
        • Table DDC-Based Nebulizer - Product Description
    • DesignWise Medical Inc (Inactive) Company Overview
      • DesignWise Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table DesignWise Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Self-Contained Nebulizer System - Product Status
        • Table Self-Contained Nebulizer System - Product Description
    • HCmed Innovations Co Ltd Company Overview
      • HCmed Innovations Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table HCmed Innovations Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Deepro - Product Status
        • Table Deepro - Product Description
    • Marquette University Company Overview
      • Marquette University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Marquette University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Human Powered Nebulizer - Product Status
        • Table Human Powered Nebulizer - Product Description
    • Parion Sciences Inc Company Overview
      • Parion Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Parion Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table tPAD Device - Product Status
        • Table tPAD Device - Product Description
    • SolAeroMed Inc Company Overview
      • SolAeroMed Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table SolAeroMed Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table S1226 Neublizer System - Product Status
        • Table S1226 Neublizer System - Product Description
    • Stirling Pharma Inc Company Overview
      • Stirling Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Stirling Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table High Density Aerosol Drug Delivery Device - Product Status
        • Table High Density Aerosol Drug Delivery Device - Product Description
    • University of California San Diego Company Overview
      • University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
        • Table Nebulizer - Product Status
        • Table Nebulizer - Product Description
    • University of Texas Medical Branch at Galveston Company Overview
      • University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
        • Table Pulse Drug Nebulization System - Product Status
        • Table Pulse Drug Nebulization System - Product Description
    • Verona Pharma Plc Company Overview
      • Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table RPL554 Nebulizer - Product Status
        • Table RPL554 Nebulizer - Product Description
    • Vincent Medical Holdings Ltd Company Overview
      • Vincent Medical Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Vincent Medical Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Home Use Ultrasonic Nebulizer - Product Status
        • Table Home Use Ultrasonic Nebulizer - Product Description
  • Nebulizers- Recent Developments
    • Nov 12, 2019: Monaghan Medical wins prestigious Zenith Award from the American Association of Respiratory Care
    • Nov 07, 2019: Cardinal Health reports first quarter results for fiscal year 2020
    • Nov 06, 2019: Owens & Minor reports 3rd quarter 2019 financial results
    • Nov 06, 2019: Owens & Minor announces new organizational structure to better serve customers
    • Oct 31, 2019: Teleflex reports third quarter 2019 results
    • Oct 30, 2019: United Therapeutics reports third quarter 2019 financial results
    • Oct 29, 2019: Vectura Group appoints New Chief Executive Officer
    • Oct 22, 2019: HCmed introduces Pulmogine in the 2019 ERS Congress
    • Oct 16, 2019: Boehringer Ingelheim announces first patient enrolled in phase II trial of novel Cystic Fibrosis treatment (BALANCE-CF 1)
    • Oct 01, 2019: New data reinforces benefits of Spiolto Respimat in improving patient outcomes
    • Oct 01, 2019: Owens & Minor appoints Robert Henkel to its board of directors
    • Sep 29, 2019: New major order from China
    • Sep 26, 2019: Vectura Group: Board Change
    • Sep 13, 2019: Vectura provides update on GSK Litigation
    • Sep 10, 2019: Vectura Group interim results for the six months ended 30 June 2019
    • Sep 10, 2019: Vectura delivers strong financial performance for H1 2019 and confirms proposed special dividend of approximately £40m in aggregate plus a £20m buyback programme
    • Sep 04, 2019: LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi encourages investors who suffered losses exceeding $100,000 in Cardinal Health to contact the firm
    • Aug 26, 2019: Change in the board of managing directors at Boehringer Ingelheim
    • Aug 12, 2019: Lead plaintiff deadline alert: Faruqi & Faruqi encourages investors who suffered losses exceeding $100,000 In Cardinal Health to contact the firm
    • Aug 08, 2019: Cardinal Health reports fourth quarter and full year results for fiscal year 2019
    • Aug 07, 2019: Mark A. Beck elected to Owens & Minor Board of Directors
    • Aug 07, 2019: Owens & Minor reports 2nd quarter 2019 financial results
    • Aug 07, 2019: Dean Scarborough and John Weiland to join Cardinal Health's Board of Directors
    • Aug 01, 2019: Teleflex reports second quarter 2019 results
    • Aug 01, 2019: First half 2019: High levels of investment in R&D and robust organic growth
    • Jul 31, 2019: United Therapeutics reports second quarter 2019 financial results
    • Jul 25, 2019: Owens & Minor expands Senior Leadership team to Accelerate Company Growth
    • Jul 22, 2019: Owens & Minor names Mark Zacur as SVP, Chief Procurement Officer
    • Jul 17, 2019: Vectura confirms R&D investment priorities, announces a proposed £50 million capital return and a pre-close trading update
    • Jul 16, 2019: Cardinal Health appoints Stephen Mason to lead medical segment
    • Jul 08, 2019: Cardinal Health: Departure of CFO
    • Jun 10, 2019: Vectura Group announces leadership changes
    • May 20, 2019: Respivant Sciences announces dosing of first patient in phase 2b trial of RVT-1601 for the treatment of persistent cough due to idiopathic pulmonary fibrosis
    • May 20, 2019: New phase 3 data show sustainability and durability of culture conversion with ARIKAYCE (amikacin liposome inhalation suspension) in patients with refractory MAC lung disease
    • May 09, 2019: Cardinal Health Reports Third Quarter Results for Fiscal Year 2019
    • May 07, 2019: Verona Pharma initiates additional phase 2b clinical trial with Nebulized Ensifentrine to inform dose selection for phase 3 trials
    • May 07, 2019: Owens & Minor Reports 1st Quarter 2019 Financial Results
    • May 04, 2019: Vectura wins US GSK Patent Litigation and awarded $89.7Million in damages by Trial Jury
    • May 02, 2019: Teleflex reports first quarter 2019 results
    • May 01, 2019: United Therapeutics reports first quarter 2019 financial results
    • Apr 26, 2019: Nationally recognized expert in consumerism joins Henry Ford Health System
    • Apr 17, 2019: Financial year 2018: Boehringer Ingelheim grows and invests
    • Apr 09, 2019: Insmed granted additional U.S. patent for ARIKAYCE (amikacin liposome inhalation suspension), strengthening brands global patent portfolio
    • Apr 09, 2019: Henry Ford Health System names two new senior leaders
    • Apr 08, 2019: Insmed provides update on ARIKAYCE (amikacin liposome inhalation suspension) U.S. Launch
    • Apr 08, 2019: Owens & Minor names Jeffrey Jochims as Executive Vice President, Strategy & Solutions
    • Apr 01, 2019: Insmed to showcase new ARIKAYCE (amikacin liposome inhalation suspension) and pipeline data at American Thoracic Society International Conference
    • Apr 01, 2019: Vectura Group names Kevin Matthews to its board of directors
    • Mar 26, 2019: Vectura Group 2018 preliminary results
    • Feb 27, 2019: United Therapeutics announces 2018 fourth quarter and annual financial results
    • Feb 25, 2019: Boehringer Ingelheim: New chief medical officer appointed
    • Feb 21, 2019: Teleflex reports fourth quarter and full year 2018 results; provides 2019 guidance
    • Feb 19, 2019: Owens & Minor appoints Ed Pesicka as President and Chief Executive Officer
    • Feb 19, 2019: Owens & Minor Reports 4th Quarter & Full-Year 2018 Financial Results
    • Feb 07, 2019: Cardinal Health reports second quarter results for fiscal year 2019
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook